We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BMRA market cap is 9.71M. The company's latest EPS is USD -0.4245 and P/E is -1.37.
| Quarter End | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 | Feb 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.11M | 1.11M | 1.71M | 1.57M | 1.02M |
| Operating Income | -1.65M | -1.84M | -1.23M | -1.61M | -2.06M |
| Net Income | -1.65M | -1.79M | -1.13M | -1.51M | -1.92M |
| Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.2M | 6.69M | 7.2M | 18.87M | 5.34M |
| Operating Income | -2.51M | -2.4M | -6.52M | -4.53M | -7.22M |
| Net Income | -2.49M | -2.34M | -6.47M | -4.53M | -7.14M |
| Quarter End | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 | Feb 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.21M | 14.45M | 13.22M | 11.83M | 10.34M |
| Total Liabilities | 2.22M | 2.73M | 2.45M | 2.45M | 2.53M |
| Total Equity | 5.99M | 11.72M | 10.77M | 9.38M | 7.81M |
| Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.25M | 17.26M | 11.82M | 11.37M | 14.45M |
| Total Liabilities | 1.26M | 3.05M | 2.59M | 3.05M | 2.73M |
| Total Equity | 3.98M | 14.21M | 9.23M | 8.33M | 11.72M |
| Quarter End | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 | Feb 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.51M | -5.44M | -1.67M | -2.52M | -4.32M |
| Investing | -64k | -78k | -63k | -75k | -91k |
| Financing | 2.04M | 9.39M | N/A | N/A | N/A |
| Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.24M | -4.3M | -5.25M | -481k | -5.44M |
| Investing | -171k | -119k | -295k | -170k | -78k |
| Financing | 1.91M | 12.37M | 1.11M | 2.4M | 9.39M |
| Market Cap | 9.71M |
| Price to Earnings Ratio | -1.37 |
| Price to Sales Ratio | 1.83 |
| Price to Cash Ratio | 1 |
| Price to Book Ratio | 0.83 |
| Dividend Yield | - |
| Shares Outstanding | 16.82M |
| Average Volume (1 week) | 53.62k |
| Average Volume (1 Month) | 51.58k |
| 52 Week Change | -61.66% |
| 52 Week High | 2.13 |
| 52 Week Low | 0.50 |
| Spread (Intraday) | 0.25 (31.21%) |
| Company Name | Biomerica Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.biomerica.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
